Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog selective inhibitors for acute myeloid leukemia treatment Meeting Abstract


Authors: Benajiba, L.; Wagner, F.; Campbell, A.; Weiwer, M.; Joshua, S.; Gale, J.; Ross, L.; Puissant, A.; Alexe, G.; Conway, A.; Back, M.; Pikman, Y.; Galinsky, I.; DeAngelo, D. J.; Stone, R. M.; Kaya, T.; Shi, X.; Robers, M.; Machleidt, T.; Hermine, O.; Kung, A. L.; Stein, A.; Hemann, M.; Scolnick, E.; Zhang, Y. L.; Pan, J.; Holson, E.; Stegmaier, K.
Abstract Title: Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog selective inhibitors for acute myeloid leukemia treatment
Meeting Title: 59th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 130
Issue: Suppl. 1
Meeting Dates: 2017 Dec 9-12
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2017-12-07
Language: English
ACCESSION: WOS:000432419405130
PROVIDER: wos
DOI: 10.1182/blood.V130.Suppl_1.2075.2075
Notes: Meeting Abstract: 2075 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew L Kung
    97 Kung